MDNA11 Generates Activity, Safety in Advanced Solid Tumors
August 9, 2023Chris RyanTreatment with the long-acting interleukin-2 superkine led to durable tumor control and no dose-limiting toxicities in patients with advanced solid tumors, according to data fr
Updated on: October 12,2023
185
MDNA11 Generates Activity, Safety in Advanced Solid Tumors
August 9, 2023Chris RyanTreatment with the long-acting interleukin-2 superkine led to durable tumor control and no dose-limiting toxicities in patients with advanced solid tumors, according to data fr
Updated on:October 12,2023
185
